Clinical Trials Browser

OTHER × Cholangiocarcinoma × olaparib × Clear all

NCT04306367 2025-02-17

Study of Pembrolizumab and Olaparib in Bile Duct Cancer

Phase 2 Completed

14 enrolled 13 charts

Gastrointestinal

Cholangiocarcinoma

NCT03991832 2024-07-18

SOLID

Phase 2 Recruiting

CNSGastrointestinal

Glioma, Cholangiocarcinoma